Related Experiment Video
Updated: Mar 9, 2026

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
Different clinical significance of FGFR1-4 expression between diffuse-type and intestinal-type gastric cancer
Mikito Inokuchi1, Hideaki Murase2, Sho Otsuki2
1Department of Gastrointestinal Surgery, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo, Tokyo, 113-8519, Japan. m-inokuchi.srg2@tmd.ac.jp.
Background:
Receptor tyrosine kinases promote tumor progression in many cancers, although oncologic activation differs between diffuse-type gastric cancer (DGC) and intestinal-type gastric cancer (IGC). Fibroblast growth factor receptor (FGFR) is one RTK, and we previously reported the clinical significance of FGFR1, 2, 3, and 4 in gastric cancer. The aim of the present study was to reevaluate the clinical significance of FGFR1-4 expression separately in DGC and IGC.
Methods:
Tumor samples, including 109 DGCs and 100 IGCs, were obtained from patients who underwent gastrectomy between 2003 and 2007 in our institution. The expression levels of FGFR1, 2, 3, and 4 were measured in the tumors by immunohistochemical analysis.
Results:
In DGC, high expression of FGFR1, FGFR2, or FGFR4 was significantly associated with the depth of invasion, lymph-node metastasis, pathological stage, and distant metastasis or recurrent disease. Patients with high expression of FGFR1, FGFR2, or FGFR4 had significantly poorer disease-specific survival (DSS) (p = 0.009, p = 0.001, and p = 0.023, respectively). In IGC, only FGFR4 expression was significantly associated with factors relative to tumor progression and with shorter DSS (p = 0.012).
Conclusion:
In conclusion, high FGFR4 expression correlated with tumor progression and survival in both DGC and IGC, whereas high expression of FGFR1 and 2 correlated with tumor progression and survival in only DGC.
Insights
Fibroblast growth factor receptor (FGFR) expression impacts gastric cancer progression. High FGFR4 correlates with poor survival in both diffuse-type (DGC) and intestinal-type gastric cancer (IGC), while FGFR1 and FGFR2 are linked to poorer outcomes only in DGC.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Receptor tyrosine kinases (RTKs) drive tumor progression, with distinct activation patterns in diffuse-type gastric cancer (DGC) and intestinal-type gastric cancer (IGC).
- Fibroblast growth factor receptors (FGFRs) are key RTKs implicated in various cancers.
- Previous research highlighted the clinical significance of FGFR1-4 in gastric cancer.
Purpose of the Study:
- To reevaluate the distinct clinical significance of FGFR1-4 expression in DGC versus IGC.
- To correlate FGFR expression levels with tumor progression and patient survival in both gastric cancer subtypes.
Main Methods:
- Immunohistochemical analysis of FGFR1, FGFR2, FGFR3, and FGFR4 expression in 109 DGC and 100 IGC tumor samples.
- Tumor samples were collected from patients who underwent gastrectomy between 2003 and 2007.
Main Results:
- In DGC, high FGFR1, FGFR2, or FGFR4 expression correlated with increased tumor invasion, lymph-node metastasis, advanced pathological stage, and distant metastasis or recurrence.
- Patients with high FGFR1, FGFR2, or FGFR4 expression in DGC exhibited significantly poorer disease-specific survival (DSS).
- In IGC, only high FGFR4 expression was significantly associated with tumor progression and shorter DSS.
Conclusions:
- High FGFR4 expression is a significant indicator of tumor progression and reduced survival in both DGC and IGC.
- High FGFR1 and FGFR2 expression are associated with tumor progression and survival specifically in DGC.
- These findings underscore the subtype-specific roles of FGFRs in gastric cancer pathogenesis and prognosis.
Related Concept Videos
Gastritis-I: Introduction and Types
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Mitogens and the Cell Cycle

